Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01424293 · ClinicalTrials.gov registry record · NA
Fluorescent Evaluation of Colorectal Anastamoses
A NA study, sponsored by Maimonides Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01424293 is a NA study that has completed, run by Maimonides Medical Center. The registered enrollment target is 7 participants.
The verdict
NCT01424293, a NA study, has completed, sponsored by Maimonides Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Bowel removal is indicated for various types of colon and rectal disease, including colon cancer, rectal cancer, diverticulitis, and inflammatory bowel disease among others. Following removal of the diseased segment of bowel your surgeon will reconnect the two healthy ends to reconstruct a continuous bowel tube. If the bowel leaks it can become an extremely dangerous situation. The cause of leakage has many causes and is not well understood, but appears to be at least in part due to not having enough blood going to the bowel. There is currently no way to evaluate the blood supply to the bowel. The purpose of this study is to utilize a special camera to evaluate the blood supply of the bowel. This new system is called the Spy-scope. This system may assist surgeons in reducing the occurrence of leaks
Interventions
- DEVICE Indocyanine Green
- DEVICE The SPY® Intraoperative Imaging System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-05 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01424293
The ClinicalTrials.gov registry entry for NCT01424293 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maimonides Medical Center, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Indocyanine Green is the first listed.
NCT01424293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01424293 about?
NCT01424293 is a clinical study titled "Fluorescent Evaluation of Colorectal Anastamoses". Bowel removal is indicated for various types of colon and rectal disease, including colon cancer, rectal cancer, diverticulitis, and inflammatory bowel disease among others. Following removal of the diseased segment of bowel your surgeon will reconnect the two healthy ends to reconstruct a continuo...
What is the current status of trial NCT01424293?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2010-05. Estimated completion is 2016-09.
What interventions are being tested in trial NCT01424293?
The interventions under investigation include: Indocyanine Green (DEVICE), The SPY® Intraoperative Imaging System (DEVICE).
Who is sponsoring clinical trial NCT01424293?
This trial is sponsored by Maimonides Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.